Kari Pekka Pitkänen
Director/Board Member at Scellex Oy
Net worth: 6 M $ as of 2024-06-29
Profile
Kari Pekka Pitkänen founded Aiforia Technologies Oyj in 2013, where he worked as Director-Business Development from 2021 to 2023.
Mr. Pitkänen also currently works at Scellex Oy, as Director from 2019 and Genna Health Oy, as Director from 2020.
Mr. Pitkänen also formerly worked at Finnzymes Oy, as Marketing Director.
Mr. Pitkänen received his graduate degree from Aalto University School of Science & Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-08-30 | 1,181,000 ( 4.09% ) | 6 M $ | 2024-06-29 |
Kari Pekka Pitkänen active positions
| Companies | Position | Start |
|---|---|---|
| Scellex Oy | Director/Board Member | 2018-12-31 |
| Genna Health Oy | Director/Board Member | 2019-12-31 |
Former positions of Kari Pekka Pitkänen
| Companies | Position | End |
|---|---|---|
| AIFORIA TECHNOLOGIES OYJ | Founder | 2022-12-31 |
Finnzymes Oy
 Finnzymes Oy Pharmaceuticals: MajorHealth Technology The company is part of Thermo Fisher Scientific, the world leader in serving science. Thermo Fisher Scientific enables customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. With annual sales of more than $9 billion, Thermo Fisher Scientific has over 30,000 employees and serves more than 350,000 customers in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies as well as environmental, industrial quality and process control settings. Finnzymes, founded in 1986, is a leader in the development of PCR, quantitative real-time PCR, transposon and RNA technologies. Its aim is to develop products which make the difference, products that deliver results not achievable otherwise. | Sales & Marketing | - |
Training of Kari Pekka Pitkänen
| Aalto University School of Science & Technology | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AIFORIA TECHNOLOGIES OYJ | Technology Services |
| Private companies | 3 |
|---|---|
Finnzymes Oy
Finnzymes Oy Pharmaceuticals: MajorHealth Technology The company is part of Thermo Fisher Scientific, the world leader in serving science. Thermo Fisher Scientific enables customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. With annual sales of more than $9 billion, Thermo Fisher Scientific has over 30,000 employees and serves more than 350,000 customers in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies as well as environmental, industrial quality and process control settings. Finnzymes, founded in 1986, is a leader in the development of PCR, quantitative real-time PCR, transposon and RNA technologies. Its aim is to develop products which make the difference, products that deliver results not achievable otherwise. | Health Technology |
| Scellex Oy | |
| Genna Health Oy |
- Stock Market
- Insiders
- Kari Pekka Pitkänen
